Lancet Oncology

A shot in the dark
pp. 3-3(1)

The Lancet Oncology-Instructions to authors
pp. 4-4(1)

Proteomics may aid bladder cancer diagnosis
pp. 5-5(1)
Author: Sansom C.

Ethics of placebo-controlled trials under discussion
pp. 5-5(1)
Author: Hutchinson E.

Evidence strengthened for role of BRCA1 in transcription control
pp. 6-6(1)
Author: Bradbury J.

High risk of cervical cancer in HIV-infected women
pp. 6-6(1)
Author: Bosch X.

Better prospects for myeloma patients
pp. 7-7(1)
Author: Bonn D.

Antisense oligonucleotides suppress tumour growth
pp. 7-7(1)
Author: Habeck M.

New virtual computer on trial
pp. 8-8(1)
Author: Kenyon G.

Potent anti-cancer drug from witches' umbrella
pp. 8-8(1)
Author: Stephenson J.

Indian centre develops teletherapy machine for cervical cancer
pp. 9-9(1)
Author: Sharma D.C.

Melanoma vaccine launch may be too early
pp. 9-9(1)
Author: Howe M.

Ray of light for treatment of head and neck cancer
pp. 10-10(1)
Author: Morris K.

Rise and temporary fall of Indian oncology journals
pp. 10-10(1)
Author: Pai S.A.

A few steps closer to understanding the molecular basis of breast cancer
pp. 11-11(1)
Author: Senior K.

Hereditary cancer
pp. 12-12(1)
Authors: Evans G.; Eeles R.

Hereditary cancer - Authors' reply
pp. 12-13(2)
Authors: Emery J.; Murphy M.; Lucassen A.

PSA assays
pp. 13-13(1)
Author: Ablin R.J.

Trends in prostate cancer mortality in England, Wales, and the USA
pp. 14-14(1)
Author: Bishop M.C.

PSA doubling times
pp. 14-15(2)
Author: Newcombe H.

Importance of field cancerisation in clinical oncology
pp. 15-16(2)
Authors: Vauthey J.-N.; Walsh G.L.; Vlastos G.; Lauwers G.Y.

Quantitating quality of life
pp. 16-16(1)
Author: Pritchard J.

Prostate cancer: to screen or not to screen?
pp. 17-24(8)
Authors: Neal D.E.; Donovan J.L.

Clinical picture - Cutaneous B cell lymphoma arising from a chronically inflamed sebaceous cyst
pp. 24-24(1)
Authors: Camidge D.; Matheson L.

The role of hypoxia-activated prodrugs in cancer therapy
pp. 25-29(5)
Author: Denny W.A.

Advances in three-dimensional conformal radiation therapy physics with intensity modulation
pp. 30-36(7)
Author: Webb S.

Ethnicity and oral cancer
pp. 37-42(6)
Authors: Scully C.; Bedi R.

Tamoxifen: a personal retrospective
pp. 43-49(7)
Author: Jordan V.C.

Axel Ullrich - a pioneer in gene technology - Interviewed by Ezzie Hutchinson for The Lancet Oncology
pp. 50-53(4)

'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say.
pp. 54-55(2)
Author: Ernst E.

'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say.
pp. 55-56(2)
Authors: Cohen L.; Gerner J.; Baile W.

'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say.
pp. 56-57(2)
Author: Schraub S.

'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say.
pp. 57-58(2)
Author: Diamond J.

'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say.
pp. 58-59(2)
Author: Ross E.

De Libris
pp. 60-60(1)
Author: Bridgewater J.

De Libris
pp. 60-60(1)
Author: Boddy A.

De Libris
pp. 61-61(1)
Author: Jones A.L.

CancerBACUP - a great resource for patients and doctors - www.cancerbacup.org.uk
pp. 62-62(1)
Author: Patrick T.

Rates and risks - http://rex.nci.nih.gov/NCI_Pub_Interface/raterisk/index.html
pp. 62-62(1)
Author: Fay M.

New section to Oncolink - http://www.oncolink.upenn.edu/specialty/complementary/
pp. 63-63(1)
Author: Hoyland W.

Plumbing the human genome
pp. 64-64(1)
Author: Lee J.A.